NCT04512495
- Conditions
- Leiomyosarcoma, Liposarcoma, Liposarcoma, Myxoid, +11 more
- Locations
-
- Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France
Clinical trial condition
Liposarcoma
Explore clinical trials studying Liposarcoma. Study availability and eligibility vary by location and protocol.
123 public trials
26 recruiting studies
Liposarcoma trial results
NCT02247544
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +21 more
- Locations
-
- Istituto Tumori Giovanni Paolo II Bari, BA, Italy
- Azienda Ospedaliera Giovanni Paolo XXIII Bergamo, BG, Italy
- Azienda Ospedaliera S. Orsola-Malpighi Bologna, BO, Italy
- A.O. Spedali Civili Brescia, BS, Italy
Completed
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
NCT01532687
- Conditions
- Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, +48 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Ph II Cabazitaxel DD Liposarcoma
NCT01913652
- Conditions
- Dedifferentiated Liposarcoma, Liposarcoma, Neoplasms, +4 more
- Locations
-
- Universitair Ziekenhuis Antwerpen (117) Antwerp, Belgium
- Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet (101) Brussels, Belgium
- CHU de Dijon - Centre Georges-Francois-Leclerc (229) Dijon, France
- Centre Leon Berard (227) Lyon, France
NCT00423618
- Conditions
- Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiopericytoma, Malignant, +26 more
- Locations
-
- Royal Orthopedic Hospital NHS Trust Birmingham, England, United Kingdom
- Christie Hospital Manchester, England, United Kingdom
- Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom
- Nottingham City Hospital Nottingham, England, United Kingdom
Completed
Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
NCT02343172
- Conditions
- Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Bordeaux, France
- Novartis Investigative Site Lyon, France
- Novartis Investigative Site Essen, Germany
Completed
The FGF/FGFR Signalling Pathway:
NCT03303885
- Conditions
- Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Nice Hospital Nice, France
NCT01692496
- Conditions
- Advanced and / or Metastatic Liposarcoma, Liposarcoma, Neoplasm Metastasis, +8 more
- Locations
-
- HELIOS Klinikum Berlin-Buch (Sarkomzentrum Berlin-Brandenburg) Berlin, Germany
- Universitätsklinikum EssenInnere Klinik (Tumorforschung) Essen, Germany
- Medizinische Hochschule Hannover (Zentrum Innere Medizin) Hanover, Germany
- Universitätsmedizin Mannheim (Sarkomzentrum) Manheim, Germany
Completed
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
NCT00949325
- Conditions
- Chondrosarcoma, Fibrosarcoma, Histiocytoma, +26 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Completed
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
NCT01614795
- Conditions
- Childhood Alveolar Soft Part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, +34 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Loma Linda University Medical Center Loma Linda, California, United States